Tongguan capsule ameliorates coronary artery stenosis in a 40-year-old woman.

Abstract

Cardiovascular disease is the leading cause of death worldwide, with coronary heart disease as the major contributor to this related mortality. There is a growing trend in the application of Chinese medicine in clinical practice for the treatment of coronary heart disease. However, there is a lack of knowledge surrounding the pharmacological, toxicological, and biological profiles of Chinese medicine. In this case report, we describe the therapeutic effects of Tongguan capsule in a 40-year-old woman diagnosed with stable angina pectoris. To the best of the authors' knowledge, this is the first case documented of the therapeutic effect of Tongguan capsule in the treatment of coronary heart disease.

• Authors: Huan Ma, Lei Wang, Daozheng Huang, Guoqing Liu, Minzhou Zhang
• Journal: Drug design, development and therapy (Drug Des Devel Ther) Vol. 9 Pg. 4413-6 ( 2015) ISSN: 1177-8881 [Electronic] New Zealand
• PMID: 26309395 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Capsules
• Cardiovascular Agents
• Drugs, Chinese Herbal
• tongguan

Topics

• Administration, Oral
• Adult
• Angina, Stable (diagnosis, drug therapy)
• Capsules
• Cardiovascular Agents (administration & dosage)
• Coronary Angiography (methods)
• Coronary Stenosis (diagnosis, drug therapy)
• Drugs, Chinese Herbal (administration & dosage)
• Female
• Humans
• Time Factors
• Tomography, X-Ray Computed
• Treatment Outcome